Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 902219 Boston, MA

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$964,334
+$168,615 QoQ
Shares Held
257,156
-2.7% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
13 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 70.58128140117283.ToString("F0")% None 29.41871859882717.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. ACRS ranks #146 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $964,334 257,156
2025-12-31 $795,719 264,359
2023-09-30 $47,811,928 6,979,844
2023-06-30 $79,204,687 7,637,868
2023-03-31 $59,644,338 7,372,601
2022-12-31 $86,373,202 5,484,013
2022-09-30 $54,363,642 3,453,853
2022-06-30 $68,421,629 4,901,263
2022-03-31 $98,789,560 5,730,253
2021-12-31 $80,540,954 5,539,268
2021-09-30 $97,568,154 5,420,453
2021-06-30 $82,492,471 4,697,749
2021-03-31 $20,949,490 831,329